SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-070765
Filing Date
2023-12-15
Accepted
2023-12-15 16:23:51
Documents
13
Period of Report
2023-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K gern-20231214.htm   iXBRL 8-K 71085
2 EX-3.1 gern-ex3_1.htm EX-3.1 248669
  Complete submission text file 0000950170-23-070765.txt   486975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20231214_lab.xml EX-101.LAB 14941
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20231214_pre.xml EX-101.PRE 11326
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20231214.xsd EX-101.SCH 2367
7 EXTRACTED XBRL INSTANCE DOCUMENT gern-20231214_htm.xml XML 4878
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 231490686
SIC: 2834 Pharmaceutical Preparations